Download PDF
Drug Res (Stuttg) 2015; 65(10): 545-551
DOI: 10.1055/s-0034-1394417
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Neurobehavioural and Analgesic Properties of Ethanol Bark Extract of Terminalia ivorensis A Chev. (Combrataceae) in Mice

O. A. Adeoluwa
1   Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria
2   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Oyo State, Nigeria
,
A. O. Aderibigbe
2   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Oyo State, Nigeria
,
G. O. Agu
2   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Oyo State, Nigeria
,
F. A. Adewole
2   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Oyo State, Nigeria
,
A. T. Eduviere
1   Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Afe Babalola University Ado-Ekiti, Ekiti State, Nigeria
2   Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Oyo State, Nigeria
› Author Affiliations
Further Information

Publication History

received 12 July 2014

accepted 06 October 2014

Publication Date:
16 December 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Background: Terminalia ivorensis A. Chev (Combretaceae) is a medicinal plant used in folk medicine in the management of pain, rheumatic condition, gastroenteritis and as a tranquilizer in psychotic disorder.

Objective: We evaluated neurobehavioural and analgesic properties of the ethanol bark extract of T. ivorensis (EBETI).

Materials and methods: Effects of EBETI (1.25, 2.5, and 5 mg/kg) on novelty-induced behaviours were determined using open field test. Anxiolytic effect of EBETI (1.25, 2.5, and 5 mg/kg) was assessed using hole-board and elevated-plus maze paradigms. Analgesic property of EBETI (2.5, 5, and 10 mg/kg) was evaluated using acetic acid induced writhing, formalin and tail immersion tests. The extract was administered once intraperitoneally.

Results: The LD50 of EBETI was 173 mg/kg. EBETI (1.25, 2.5, and 5 mg/kg) significantly reduced rearing (142.3±1.6, 83.5±1.9, 39.3±1.5) and grooming (33.8±3.4, 28.4±3.0, 18.2±1.7) as compared with controls (180.5±4.9; 52.4±5.2). Treatment with EBETI (1.25, 2.5, and 5 mg/kg) significantly reduced head-dipping on hole-board (9.4±2.3, 6.2±1.9, 5.4±2.9) as compared with control (26.8±1.9). However, there was no anxiolytic effect on EPM. EBETI (2.5, 5, and 10 mg/kg) significantly inhibited abdominal constriction in writhing assay (21.8.0±2.4, 12.2±1.6, 5.8±2.1) as compared with control (35.0±1.7). Inhibition of neurogenic and inflammatory phases of formalin test was notice. However, the extract could not alter response to thermal stimulus in tail immersion test.

Discussion and conclusion: EBETI is sedative and has analgesic effect, thus supporting its folkloric use in pain management and as a tranquilizer in psychosis.

Key words

analgesic - neurobehaviour - Terminalia ivorensis - tranquilizer
 

  • References

  • 1 Emmanuel AC. Antioxidant and Antibacterial activities of the Chemical Constituents of Terminalia ivorensis Chev. An Unpublished B.Sc. Thesis, Department of Chemistry, Kwame Nkrumah University of Science and Technology 2008
    PubMedGoogle Scholar
  • 2 Guessan NK. Contribution à l.étude ethnobotanique en pays Krobou (République de Côte-d.Ivoire). Thèse de Doctorat de 3e cycle, F.A.S.T., Laboratoire de Botanique, Université Nationale de Côte-d.Ivoire 1995; 180-182
    PubMedGoogle Scholar
  • 3 Coulibaly K. Evaluation de l.activité antifongique des extraits d.écorces d.essences commerciales, de la catégorie P1 de la forêt classée de Mopri, Tiassalé (Sud de la Côte d.Ivoire). Mémoire D.E.A. d.Ecologie Tropicale, Option Végétale, Université de Cocody-Abidjan, U.F.R. Biosciences 2006; 23-25
    PubMedGoogle Scholar
  • 4 Zirihi GN. Contribution au recensement, à l.identification et à la connaissance de plusieurs espèces végétales en médecine traditionnelle chez les Bétés du Département d.Issia. Thèse de doctorat de 3ème Cycle, F.A.S.T., Université Nationale de Cote d.Ivoire 1991; 76-78
    PubMedGoogle Scholar
  • 5 Adjanohoun EJ, et Ake-Assi L. Contribution au recensement des plantes médicinales de Côte d.Ivoire. C.R.E.S., Université d.Abidjan, Centre National de Floristique 1979: 358
    PubMedGoogle Scholar
  • 6 Agbedahunsi JM, Anao I, Adewunmi CO et al. Trypanocidal Properties of Terminalia Ivorensis A. Chev. (Combretaceae). Afr J Trad CAM 2006; 3: 51-56
    PubMedGoogle Scholar
  • 7 Lawal IO, Uzokwe NE, Igboanugo ABI et al. Ethno medicinal information on collation and identification of some medicinal plants in Research Institutes of South-west Nigeria. African Journal of Pharmacy and Pharmacology 2010; 4: 001-007 http://www.academicjournals.org/ajpp
    PubMedGoogle Scholar
  • 8 Abbiw DK. Useful plants of Ghana: West African uses of wild and cultivated plants, short Run Press, England. 1990; 7: 84-86 88, 92, 195, 203, 225
    PubMedGoogle Scholar
  • 9 Hutchinson J, Dalziel JM. The useful plants of West Tropical Africa. Appendix to the Flora of West Tropical Africa 1936; 81-82
    PubMedGoogle Scholar
  • 10 Adewunmi CO, Agbedahunsi JM, Adebajo AC et al. Ethno-Veterinary Medicine: Screening of Nigerian medicinal plants for trypanocidal properties. J Ethnopharmacol 2001; 77: 19-24
    CrossrefPubMedGoogle Scholar
  • 11 Iwu MM, Anyawu BN. Anti-inflammatory and anti-arthritic properties of Terminalia ivorensis. Fitoterapia 1982; 52: 25-34
    PubMedGoogle Scholar
  • 12 Malcom SA, Sofowora EA. Antimicrobial activity of selected Nigerian folk remedies and their constituent plants. Lloydia 1969; 32: 512-517
    PubMedGoogle Scholar
  • 13 Ekong DEU, Idemudia OG Chem. Soc. C 863–864 In: The state of medicinal plants research in Nigeria (1966). Sofowora A, (ed.). 1967: 31-52
    Google Scholar
  • 14 Olipoh G. Antimicrobial properties of ethanol extracts of Terminalia ivorensis and Panda oleosa. BSc thesis, Chemistry Department, KNUST 2003: 34-37
    PubMedGoogle Scholar
  • 15 Lorke D. A new approach to practical acute toxicity testing. Arch Technol 1983; 54: 275-282
    PubMedGoogle Scholar
  • 16 Ajayi AA, Ukponmwan OE. Evidence of Angiotensin II and Endogenous opioid modulation of NIR in the Rat. African Journal of Medicine, Medical Science 1994; 23: 287-290
    PubMedGoogle Scholar
  • 17 Onigbogi O, Ajayi AA, Ukponmwan OE. Mechanisms of Chloroquine- Induced Body Scratching Behaviour in Rats: Evidence of involvement of endogenous opioid peptides. Pharmacology Biochemistry and Behaviour 2000; 65: 333-337
    CrossrefPubMedGoogle Scholar
  • 18 Akanmu MA, Olowookere TA, Atunwa SA et al. Neuropharmacological effects of nigerian honey in mice. African Journal of Traditional Complementary Alternative Medicine 2011; 8: 230-249
    PubMedGoogle Scholar
  • 19 Dorr M, Joycee D, Porsolt RD et al. Persistence of dose-related behaviour in mice. Nature 1971; 231: 121-123
    CrossrefPubMedGoogle Scholar
  • 20 Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987; 92: 180-185
    PubMedGoogle Scholar
  • 21 Trullas R, Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology 1993; 111: 323-331
    CrossrefPubMedGoogle Scholar
  • 22 Koster R, Anderson M, DeBeer EJ. Acetic acid for analgesic screening. Federation Proceeding 1959; 18: 412-417
    PubMedGoogle Scholar
  • 23 Santos ARS, Calixto JB. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 1997; 31: 381-389
    CrossrefPubMedGoogle Scholar
  • 24 Janssen PAJ, Niemegeers CJE, Dony JGH. The inhibitory effect of fentanyl and morphine like analgesics on the warm water-induced tail withdrawal reflex in rats. Arzneim Forsch 1963; 13: 502
    PubMedGoogle Scholar
  • 25 Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: Pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioural Reviews 2001; 25: 205-218
    CrossrefPubMedGoogle Scholar
  • 26 Labell FS, Punsky C, Havlicek V. Morphine derivatives with diminished opiate receptor potency show enhanced control excitatory activity. Brain Research 1979; 174: 263-271
    CrossrefPubMedGoogle Scholar
  • 27 Aderibigbe AO, Agboola OI. Neuropharmacological profile of Struchium sparganophora (Linn) O. Ktze in mice. Asian Journal of Traditional Medicines 2011; 6: 3
    PubMedGoogle Scholar
  • 28 Hellion-Ibarrola MC, Ibarrola DA, Montalbetti I et al. Acute toxicity and general pharmacological effect on central nervous system of the crude rhizome extract of Kyllinga brevifolia Rottb. Journal of Ethnopharmacology 1999; 66: 271-276
    CrossrefPubMedGoogle Scholar
  • 29 Gispen WH, Isaacson RL. ACTH-induced excessive grooming in the rat. Pharmacol Ther 1981; 12: 209-246
    CrossrefPubMedGoogle Scholar
  • 30 Ukponmwan OE, Poel-Heisterkamp L, Dzoljic MR. REM sleep deprivation decreases grooming and scratching behavior induced by enkephalinase inhibition or opiate withdrawal. Pharmacology Biochemistry and Behaviour 1985; 23: 385-389
    CrossrefPubMedGoogle Scholar
  • 31 Richard JB. The role of dopamine in locomotor activity and learning. Brain Research Reviews 1983; 6: 173-196
    CrossrefPubMedGoogle Scholar
  • 32 Dulawa SC, Grandy DK, Low MJ et al. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 1999; 19: 9550-9556
    PubMedGoogle Scholar
  • 33 Carlsson A, Lindquist M, Magnusson T et al. On the presence of 3 hydroxytyramine in brain. Science 1958; 129: 471-473
    PubMedGoogle Scholar
  • 34 Fray PJ, Sahakian BJ, Robbins TW et al. An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of D-amphetamine and apomorphine. Psychopharmacology 1980; 69: 253-259
    CrossrefPubMedGoogle Scholar
  • 35 Akanmu MA, Adeosu SO, Ilesanmi OR. Neuropharmacological effects of oleaminde in male and female mice. Behavioural Brain Research 2007; 182: 88-94
    CrossrefPubMedGoogle Scholar
  • 36 File SE, Wardill AG. Validity of head dipping as a measure of exploration in a modified hole-board. Psychopharmacologia 1975; 44: 53-59
    CrossrefPubMedGoogle Scholar
  • 37 Crawley JN. Exploratory behaviour models of anxiety in mice. Neuroscience and Behavioural Review 1985; 9: 37-44
    PubMedGoogle Scholar
  • 38 Gene RM, Segura L, Adzet T. Heterothe cainuloides: anti-inflammatory and analgesic effects. Journal of Ethnopharmacology 1989; 60: 157
    PubMedGoogle Scholar
  • 39 Sianchez-Mateo CC, Bonkanka CX, Herniandez-Pierez M et al Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. fil. J Ethnopharmacol 2006; 107: 1-6
    CrossrefPubMedGoogle Scholar
  • 40 Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: Systemic lidocaine suppresses phase-2 activity. Pain 1996; 64: 345-355
    CrossrefPubMedGoogle Scholar
  • 41 Hunskaar S, Berge OG, Hole K. Dissociation between antinociceptive and anti inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain 1986; 25: 125-132
    CrossrefPubMedGoogle Scholar
  • 42 Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30: 103-114
    CrossrefPubMedGoogle Scholar